MedTrace Logo

Modeling DNA Diversity in Reverse Cholesterol Transport

NCT00064493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4146

Last updated 2021-10-01

No results posted yet for this study

Summary

To identify genetic variation in reverse cholesterol transport (RCT) and its role in cardiovascular disease and atherosclerosis.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Eric Boerwinkle · University of Texas School of Public Health

  • Andrew Clark · Cornell University

  • Charles Sing · University of Michigan

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2008-05-31
Completion
2008-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064493 on ClinicalTrials.gov